Thanks pivalde,
I'll def give it a read tomorrow, big weekend, needing to catch up on some Zs.
I didnt think we needed a phase 3 with an orphan drug, but as you said, will def need it with PD when ATH434 is open to it for trials.
With the upcoming conferences, are they to have further evidence from the other participants that had not completed the 6mnths yet from the first 202 read out ?. Or even more evidence of improvement from all the 202 candidates ?.
Thanks again for the link, much appreciated.
Regards.
Thanks pivalde,I'll def give it a read tomorrow, big weekend,...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $5.491K | 1.520M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 50987030 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126437200 | 27 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |